Skip to main content

Clene Inc.

CLNN
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001822791

No open-market purchases or sales by Clene Inc. insiders were filed in the last 90 days; 33 institutions reported holding it in 13F filings for Q2 2026, worth $19.6M in total; no superinvestor holds it.

Q2 2022 vs. Q1 2022

How the institutions holding Clene Inc. changed between Q1 2022 and Q2 2022.

All holders in Q2 2022All holders in Q1 2022

13F holders of CLNN: Q1 2022 compared with Q2 2022
MeasureQ1 2022Of which not filed for Q2 2022Q2 2022Change
Holders53242−9
Shares6.27M43.2K3.54M−2.68M (−43.1%)
Value$24.7M$170.0K$8.93M−$15.6M (−63.6%)

2 institutions that held it in Q1 2022 haven't filed for Q2 2022 yet. Not filing isn't selling, so the changes leave them out.

New holders (9)

Institutions that held Clene Inc. at the end of Q2 2022 but not at the end of Q1 2022.

Institutions new to CLNN in Q2 2022
InstitutionSharesValue% of portfolio
Millennium Management LLC246,054$620.0K0.00%
Ergoteles LLC165,180$416.0K0.01%
Citadel Advisors LLC65,252$164.0K0.00%
Jane Street Group, LLC40,917$103.0K0.00%
Cubist Systematic Strategies, LLC11,470$29.0K0.00%
Engineers Gate Manager LP11,514$29.0K0.00%
Credit Suisse AG11$00.00%
Point72 Hong Kong Ltd122$00.00%
Ellevest, Inc.32$00.00%

Sold out (18)

Institutions that held Clene Inc. at the end of Q1 2022 and filed for Q2 2022 without it.

Not filed for Q2 2022 yet (2)

Institutions that held Clene Inc. at the end of Q1 2022 and haven't filed a 13F for Q2 2022. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding CLNN in Q1 2022 that haven't filed for Q2 2022
InstitutionShares, Q1 2022Value, Q1 2022
Parametric Portfolio Associates LLC40,003$158.0K
Amalgamated Financial Corp.3,152$12.0K